Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lasa & ICT explore Favipiravir therapy to fight COVID 1916-03-2020
16-03-2020
Lasa Supergenerics Ltd - 540702 - Concerns Over Spread Of Novel Coronavirus #COVID-19
The World Health Organization on Wednesday declared the rapidly spread Coronavirus outbreak a pandemic, in order to care and caution we have implemented work from home for all employees at our Head Office situated in Mumbai till further clarity, so that to reduce the probability Spread of deadly #Covid-19.13-03-2020
Lasa Supergenerics acquires Harishree Aromatics, share price locked in upper circuit
There were pending buy orders of 5,912 shares, with no sellers available.27-02-2020
Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lasa Supergenerics acquires Harishree Aromatics Chemical Private Limited.26-02-2020
Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
In Compliance with Regulation 30 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, this is to inform you that Board of Directors, inter- alia considered and approved the following on February 25,2020 : The draft scheme of amalgamation of Harishree Aromatics and Chemicals Private Limited ('HACPL') with Lasa Supergenerics Limited ('LASA') pursuant to section 230 to 232 of the Companies Act 2013.26-02-2020
Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Updates on Acquisition
In Compliance with Regulation 30 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, this is to inform you that Board of Directors, inter- alia considered and approved the following on February 25,2020 : The draft scheme of amalgamation of Harishree Aromatics and Chemicals Private Limited ('HACPL') with Lasa Supergenerics Limited ('LASA') pursuant to section 230 to 232 of the Companies Act 2013.26-02-2020
Lasa Supergenerics Ltd - 540702 - Outcome For Board Meeting Held Today I.E February 22,2020
1. Acquisition of Harishree Aromatics and Chemicals Private Limited through Scheme of Amalgamation. 2. Appointment of Merchant Bankers and other consultants to scheme.22-02-2020
Lasa Supergenerics Ltd - 540702 - Outcome For Board Meeting Held Today I.E February 22,2020
1. Acquisition of Harishree Aromatics and Chemicals Private Limited through Scheme of Amalgamation. 2. Appointment of Merchant Bankers and other consultants to scheme.22-02-2020
Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Intimation Of Board Meeting And Closure Of Trading Window
Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 30 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015, Meeting of Board of Directors of the Company is Scheduled to be held on Saturday 22, 2020 at the corporate office of the company inter-aila to consider and approve scheme of amalgamation for absorption of a Harishree Aromatics and Chemicals Private Limited. In accordance with Company's Code of Conduct, the Trading Window of the company shall be closed till February 25, 2020.18-02-2020
Lasa Supergenerics Ltd - 540702 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release Lasa Supergenerics Ltd11-02-2020